郑州安图生物工程股份有限公司第五届董事会第十次会议决议公告

Group 1 - The board of directors of Zhengzhou Antu Bioengineering Co., Ltd. held its tenth meeting of the fifth session on January 20, 2026, with all 12 directors present and no dissenting votes [2][3][5] - The board unanimously approved the proposal to conduct foreign exchange hedging business to mitigate foreign exchange risks due to increasing overseas sales and currency fluctuations [4][12][17] - The company plans to apply for loans up to RMB 1.5 billion from financial institutions to support its operations and development, with the loan amount depending on actual funding needs [6][17] Group 2 - The foreign exchange hedging business aims to stabilize foreign exchange exposure, reduce financial costs, and enhance financial stability, with a maximum transaction amount of USD 89 million or equivalent [12][13][22] - The funding for the hedging business will come from the company's own funds, and the transactions will be conducted with qualified financial institutions approved by relevant authorities [14][15] - The board has authorized the chairman or designated representatives to implement the hedging business within a 12-month period following the board's approval [16][22]